Precigen (STU:I5X) Tariff Resilience Score: 5/10 (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:I5X Precigen Inc STU:I5X
64 GF Score
Price €4.72
GF Value €5.11
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Precigen Tariff Resilience Score?

Precigen STU:I5X -2.07% 64 Tariff Resilience Score is 5 as of Jul. 27, 2026. GuruFocus rates STU:I5X with a GF Score™ of 64/100 and a GF Value™ of €5.11 (Fairly Valued). The stock has 10 warning signs investors should review. Among 1,367 Biotechnology companies, Precigen ranks better than 62.4% on this metric.

Precigen has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Precigen has Precigen's focus on biotechnology involves global partnerships and supply chains, making it moderately vulnerable to tariffs. However, its innovative products may have some pricing power to offset costs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Precigen might have Average Resilient.

Precigen  (STU:I5X) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Precigen Tariff Resilience Score Related Terms

STU:I5X vs GLUE, ZBIO, ADMA: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Precigen's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Precigen Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precigen's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Precigen's Tariff Resilience Score falls into.


STU:I5X
64GF Score
Precigen Inc STU:I5X
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Precigen (STU:I5X) has a Tariff Resilience Score of 5 as of Jul. 27, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Precigen ranks #514 out of 1367 companies in the Biotechnology industry, placing it in the top 37.6%.
Is Precigen's Tariff Resilience Score too high?
Precigen's current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Precigen's value of 5 is 25% above this industry median. Based on the distribution chart, Precigen ranks #514 out of 1367 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Precigen has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Precigen's Tariff Resilience Score compare to GLUE and ZBIO?
According to the Biotechnology industry distribution chart, Precigen ranks #514 out of 1367 companies for Tariff Resilience Score. This puts Precigen in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Precigen's value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,367 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Precigen's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Precigen's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precigen stock overvalued right now?
Based on GuruFocus' analysis, Precigen (STU:I5X) is currently considered Fairly Valued. The stock's GF Value™ is €5.11, compared to a current price of €4.72 — trading 7.6% below its estimated fair value. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Precigen's overall GF Score™ is 64/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Precigen (STU:I5X), the current Tariff Resilience Score is 5 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precigen (STU:I5X) Overvalued in 2026?

Based on GuruFocus' analysis, Precigen stock appears to be undervalued. The current stock price of €4.72 is trading 7.6% below its estimated GF Value™ of €5.11. GuruFocus considers Precigen to be Fairly Valued.

Key valuation signals for STU:I5X:

  • Tariff Resilience Score: 5
  • GF Value™: €5.11 vs. price of €4.72 (7.6% below fair value)
  • GF Score™: 64/100 with 10 warning signs
  • Industry Position: 25% above the Biotechnology median (#514 of 1367)

No single metric tells the full story. See the STU:I5X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precigen Business Description

Other Exchanges PGEN:USA
Address 20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
64GF Score

Get the complete analysis for STU:I5X

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.72
Price
€5.11
GF Value